Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease
Although many experimental studies have shown the favorable effects of zonisamide on mitochondria using models of Parkinson’s disease (PD), the influence of zonisamide on metabolism in PD patients remains unclear. To assess metabolic status under zonisamide treatment in PD, we performed a...
Main Authors: | Shin-Ichi Ueno, Shinji Saiki, Motoki Fujimaki, Haruka Takeshige-Amano, Taku Hatano, Genko Oyama, Kei-Ichi Ishikawa, Akihiro Yamaguchi, Shuko Nojiri, Wado Akamatsu, Nobutaka Hattori |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4409/8/1/14 |
Similar Items
-
Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy.
by: Akio Mori, et al.
Published: (2019-01-01) -
Non-invasive diagnostic tool for Parkinson’s disease by sebum RNA profile with machine learning
by: Yuya Uehara, et al.
Published: (2021-09-01) -
Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease
by: Shinji Saiki, et al.
Published: (2017-08-01) -
Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates
by: Suzan J. G. Knottnerus, et al.
Published: (2020-04-01) -
MRI and Infantile-Onset Leukoencephalopathy
by: J Gordon Millichap
Published: (2012-07-01)